AHCPR guidelines difficult to implement, HHS Inspector General survey concludes.
AHCPR GUIDELINE IMPLEMENTATION DIFFICULTY CITED BY 63% OF USERS in an HHS Office of the Inspector General survey of health care organizations using the clinical practice guidelines developed by the Agency for Health Care Policy & Research. According to the survey, "uncertainty about how to implement the guidelines was the most frequently cited obstacle to use," cited by 43% of respondents. While 63% of the respondents cited obstacles to implementation, 43% claimed uncertainty. Examples identified by the IG include: a nursing home staff that found a guideline difficult to read and understand; a hospital that was not sure how to use a diagnostic tool recommended in a guideline; and a hospital unsure about "the extent to which it need comply with the guideline."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth